Overexpression of MDM2 in leukemic cells in previously treated patients with chronic lymphocytic leukemia.

被引：0
|
作者：
Shinn, CA
Byrd, JC
Neuberg, DS
Flinn, IW
Grever, MR
机构：
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
[2] Walter Reed Army Med Ctr, Hematol Oncol Serv, Washington, DC 20307 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2422
引用
收藏
页码：542A / 542A
页数：1
相关论文
共 50 条
  • [1] EFFECT OF ADHERENCE AND DOSE INTENSITY OF IBRUTINIB ON OUTCOMES IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA.
    Deisinger, Sara
    McNally, Gretchen
    Suzuki, Sam
    Cole, George
    Byrd, John C.
    Barr, Paul M.
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 131 - 131
  • [2] Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Stilgenbauer, Stephan
    Seymour, John F.
    Huang, David C. S.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4527 - 4533
  • [3] MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (03) : 220 - 220
  • [4] Leustatin(R) in the treatment of patients with previously untreated chronic lymphocytic leukemia.
    Tallman, MS
    Wollins, E
    Jain, V
    Schiller, G
    Shepherd, J
    Silver, R
    Peterson, L
    BLOOD, 1997, 90 (10) : 2574 - 2574
  • [5] Phase II multicenter trial of pentostatin and rituximab in patients with previously treated or untreated chronic lymphocytic leukemia.
    Drapkin, R
    Di Bella, NJ
    Cuasay, LC
    Edelman, G
    Richards, D
    Mirabel, M
    Asmar, L
    BLOOD, 2002, 100 (11) : 803A - 803A
  • [6] Overexpression of the MDM2 oncogene in leukemia and lymphoma
    Watanabe, T
    Ichikawa, A
    Saito, H
    Hotta, T
    LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) : 391 - 397
  • [7] Overexpression of MDM2 in acute childhood lymphoblastic leukemia
    Gustafsson, B
    Stal, O
    Gustafsson, B
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1998, 15 (06) : 519 - 526
  • [8] MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL
    Dong, Hua-Jie
    Fang, Cheng
    Fan, Lei
    Zhu, Dan-Xia
    Wang, Dong-Mei
    Zhu, Hua-Yuan
    Zhuang, Yun
    Miao, Kou-Rong
    Liu, Peng
    Xu, Wei
    Li, Jian-Yong
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) : 2054 - 2061
  • [9] THE MDM2 ONCOGENE OVEREXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND LOW-GRADE LYMPHOMA OF B-CELL ORIGIN
    WATANABE, T
    HOTTA, T
    ICHIKAWA, A
    KINOSHITA, T
    NAGAI, H
    UCHIDA, T
    MURATE, T
    SAITO, H
    BLOOD, 1994, 84 (09) : 3158 - 3165
  • [10] Investigation of MDM2 Oncogene Copy Number Alterations in Cases of Chronic Lymphocytic Leukemia
    Darbas, Sule
    Aydin, Cigdem
    Salim, Ozan
    Karauzum, Sibel Berker
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (02) : 126 - 127
12345